Saccharomyces cerevisiae prevents postoperative recurrence of Crohn's disease modeled by ileocecal resection in HLA-B27 transgenic rats

Figure 12  Interleukin-23 mRNA expression in the anastomotic mucosa. A: Expression of interleukin (IL)-23 mRNA in the perianastomotic mucosa in all transgenic (Tg) and nontransgenic (nTg) groups at sacrifice; B: IL-23 mRNA expression between surgery [week (W) 12] and sacrifice (W18) in paired Tg rats receiving adherent-invasive Escherichia coli strain LF82 alone; C: IL-23 mRNA expression between W12 and W18 in paired Tg rats receiving coadministration of Saccharomyces cerevisiae (S. cerevisiae) CNCM I-3856 and LF82; D: IL-23 mRNA expression between W12 and W18 in paired Tg rats receiving S. cerevisiae CNCM I-3856 alone. ^aP < 0.05, ^bP < 0.01. β-act: β-actin; PBS: Phosphate buffered saline.